Final results of the EORTC intergroup randomized phase III study 40983 (EPOC) evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. - Nordlinger,B.; Sorbye,H.; Collette,L. (J Clin Oncol, 2007)